Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Revenue

In the year 2024, Xvivo Perfusion AB had annual revenue of 822.42M SEK with 37.63% growth. Xvivo Perfusion AB had revenue of 227.56M in the quarter ending December 31, 2024, with 46.12% growth.

• Revenue: 822.42M
• Revenue Growth: +37.63%
• P/S Ratio: 17.56
• Revenue / Employee: 4.84M
• Employees: 170
• Market Cap: 14.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	822.42M	224.87M	37.63%
Dec 31, 2023	597.54M	182.25M	43.88%
Dec 31, 2022	415.29M	156.91M	60.73%
Dec 31, 2021	258.39M	78.53M	43.66%
Dec 31, 2020	179.86M	-40.98M	-18.55%